Early response evaluation using multiparametric high-field MRI in locally advanced rectal cancer under neoadjuvant chemoradiotherapy

Not Applicable

• Conditions: C20; Malignant neoplasm of rectum

• Registration Number: DRKS00025258
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2018-10-15
• Study Start: 2021-06-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 55

Inclusion Criteria

Patients with initial diagnosis of rectal cancer in clinical stages T3, T4 and N +

Exclusion Criteria

MRI contraindications

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To determine the smallest parameter set that is sufficient for decision-making and to derive a prognosis score from it.

Secondary Outcome Measures

Name	Time	Method
histopathological processing of the surgical specimens